U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.50% to 37,574.66 while the NASDAQ rose 0.50% to 15,068.50. The S&P 500 also rose, gaining, 0.45% to 4,776.17.
Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion. RayzeBio shares gained 100% to $61.38 on Tuesday.
PARTS iD, Inc. today announced that it has received written notice from the NYSE American LLC stating that it is not in compliance with the continued listing standard set forth in Section 1003 of...
U.S. stocks traded mixed midway through trading, with the Dow Jones falling more than 100 points on Monday. The Dow traded down 0.40% to 34,362.93 while the NASDAQ rose 0.78% to 13,394.60. The S&P 500, also rose, gaining, 0.12% to 4,374.89.
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. Following the market opening Monday, the Dow traded down 0.11% to 34,461.22 while the NASDAQ rose 0.95% to 13,416.64. The S&P 500, also rose, gaining, 0.39% to 4,386.63.
/PRNewswire/ -- The automotive tires e-retailing market size is forecast to increase by USD 10,797.53 million from 2022 to 2027, at a CAGR of 15.3%, according...
PARTS iD, Inc. the owner and operator of, among other verticals, “CARiD.com,” a leading digital commerce platform for the automotive aftermarket, today announced that board member Lev... | April 26, 2023
/PRNewswire/ -- According to Technavio, the global automotive aftermarket e-retailing market size is estimated to grow by USD 79,605.34 million between 2022...
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter,...
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms...
TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company\’s next-generation tec...